VIGNOZZI, LINDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.924
EU - Europa 9.111
AS - Asia 2.493
OC - Oceania 168
AF - Africa 69
SA - Sud America 25
Continente sconosciuto - Info sul continente non disponibili 1
Totale 26.791
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.874
RU - Federazione Russa 3.470
IT - Italia 1.767
PL - Polonia 1.340
IE - Irlanda 853
HK - Hong Kong 684
SG - Singapore 673
SE - Svezia 634
CN - Cina 543
FI - Finlandia 191
DE - Germania 184
IN - India 183
AU - Australia 168
CH - Svizzera 165
GB - Regno Unito 145
UA - Ucraina 123
JO - Giordania 122
ID - Indonesia 94
NL - Olanda 55
VN - Vietnam 55
CI - Costa d'Avorio 53
TR - Turchia 53
CA - Canada 47
AT - Austria 45
JP - Giappone 35
ES - Italia 34
FR - Francia 32
KR - Corea 19
BE - Belgio 17
RO - Romania 16
BR - Brasile 14
LT - Lituania 13
IR - Iran 8
PH - Filippine 8
TW - Taiwan 7
SC - Seychelles 6
MD - Moldavia 5
ZA - Sudafrica 5
AR - Argentina 4
GR - Grecia 4
CO - Colombia 3
MU - Mauritius 3
MX - Messico 3
BA - Bosnia-Erzegovina 2
BD - Bangladesh 2
EC - Ecuador 2
EE - Estonia 2
HR - Croazia 2
IL - Israele 2
MK - Macedonia 2
NG - Nigeria 2
PT - Portogallo 2
TM - Turkmenistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
BY - Bielorussia 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
NO - Norvegia 1
PE - Perù 1
SM - San Marino 1
Totale 26.791
Salva come PNG Salva come JPEG
Città #
Santa Clara 3.733
Fairfield 1.736
Warsaw 1.334
Ashburn 1.006
Chandler 925
Dublin 849
Woodbridge 799
Seattle 747
Houston 730
Cambridge 638
Wilmington 568
Singapore 528
Hong Kong 459
Altamura 369
Lawrence 366
Ann Arbor 255
Princeton 244
Florence 242
Moscow 222
Jacksonville 210
Melbourne 164
Bern 158
Boston 145
Beijing 138
Mumbai 136
San Diego 130
Buffalo 120
Medford 112
Rome 111
Boardman 106
Shanghai 101
Jakarta 94
Milan 92
New York 70
Falls Church 62
Kent 56
Abidjan 53
Helsinki 52
Dong Ket 46
Redwood City 43
Vienna 38
Los Angeles 37
Norwalk 36
Hillsboro 32
London 32
Okayama 30
West Jordan 29
Izmir 28
Barcelona 26
Dearborn 24
Munich 24
Yubileyny 24
Bologna 23
Toronto 23
Lappeenranta 22
Pune 22
Andover 21
Guangzhou 20
Brussels 16
Naples 16
Detroit 14
Salerno 14
Ottawa 13
Shenzhen 13
Redmond 12
Verona 12
Palermo 11
Chennai 10
Seoul 10
Villanova Mondovì 10
Bremen 9
Las Vegas 9
Trieste 9
Auburn Hills 8
Falkenstein 8
Messina 8
Turin 8
Bari 7
Barnet 7
Chicago 7
Haarlem 7
Istanbul 7
Laurel 7
Lucca 7
Marciano della Chiana 7
Paris 7
Phoenix 7
Washington 7
Barletta 6
Bloomington 6
Camparada 6
Fontebuona 6
Forlì 6
Frankfurt Am Main 6
Frankfurt am Main 6
Haltern am See 6
Hefei 6
Omaha 6
Padova 6
Prescot 6
Totale 18.799
Salva come PNG Salva come JPEG
Nome #
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) 460
Metabolic syndrome and lower urinary tract symptoms: the role of inflammation 251
THE USE OF TADALAFIL TO TREAT LOWER URINARY TRACT SYMPTOMS AND ERECTILE DYSFUNCTION IN MEN WITH BENIGN PROSTATIC HYPERPLASIA: A SYSTEMATIC REVIEW 247
Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit. 245
Negative Effects of High Glucose Exposure in Human Gonadotropin-Releasing Hormone Neurons 242
Benign Prostatic Hyperplasia: A New Metabolic Disease of the Aging Male and Its Correlates with Sexual Dysfunctions 239
Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study. 214
Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study 211
Insulino-resistenza e fertilità nella donna con attenzione a sindrome dell'ovaio policistico (PCOS) e malattia epatica non alcoolica (NAFLD) 206
Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational Trial. 192
Androgens regulate Phosphodiesterase type 5 expression and functional activity in corpora cavernosa 187
Meta-analysis of metabolic syndrome and prostate cancer 186
INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function 184
Tumor Necrosis Factor α Impairs Kisspeptin Signaling in Human Gonadotropin-Releasing Hormone Primary Neurons 183
Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis. 177
Acute effects on human sperm exposed in vitro to cadmium chloride and diisoutyl-phthalate 164
Cardiometabolic Risk and Female Sexuality: Focus on Clitoral Vascular Resistance 164
Role of Androgens in Female Genitourinary Tissue Structure and Function: Implications in the Genitourinary Syndrome of Menopause. 161
Differential Effects of Testosterone and Estradiol on Clitoral Function: An Experimental Study in Rats 154
Testosterone improves muscle fiber asset and exercise performance in a metabolic syndrome model. 154
The non-aromatizable androgen dihydrotestosterone (DHT) facilitates sexual behavior in ovariectomized female rats primed with estradiol. 152
Physical activity counteracts metabolic syndrome-induced hypogonadotropic hypogonadism and erectile dysfunction in the rabbit. 151
Hypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men 149
Psychosexual Correlates of Unwanted Sexual Experiences in Women Consulting for Female Sexual Dysfunction According to Their Timing Across the Life Span 148
Insight on the intracrinology of menopause: androgen production within the human vagina 148
Brain Sex Differences Related to Gender Identity Development: Genes or Hormones? 147
The Impact of Central Obesity on Storage Luts and Urinary Incontinence After Prostatic Surgery 146
Cardiopulmonary protective effects of the selective FXR agonist obeticholic acid in the rat model of monocrotaline-induced pulmonary hypertension. 144
Acute vardenafil administration improves bladder oxygenation in spontaneously hypertensive rats. 142
Identification, localization and functional in vitro and in vivo activity of oxytocin receptor in the rat penis. 140
Hormonal Treatment Effect on Sexual Distress in Transgender Persons: 2-Year Follow-Up Data 139
Identification, characterization and biological activity of oxytocin receptor in the developing human penis. 137
Testosterone regulates RhoA/Rho-kinase signaling in two distinct animal models of chemical diabetes. 137
Clinical characteristics of men complaining of premature ejaculation together with erectile dysfunction: a cross-sectional study. 135
Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells. 135
Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis 135
Changes in sex hormone levels after radical prostatectomy: Results of a longitudinal cohort study. 134
5α-Reductase-2 deficiency: is gender assignment recommended in infancy? Two case-reports and review of the literature 134
Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract. 134
Nomegestrol acetate/17beta-estradiol does not negatively alter the vascular resistance of clitoral arteries: a prospective, exploratory study 133
A Randomized, Placebo-Controlled Study to Assess Safety andEfficacy of Vardenafil 10 mg and Tamsulosin 0.4 mg vs. Tamsulosin 0.4 mg Alone in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. 133
Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: A role for GPR30/GPER? 132
METABOLIC SYNDROME-ASSOCIATED SPERM ALTERATIONS IN AN EXPERIMENTAL RABBIT MODEL: RELATION WITH METABOLIC PROFILE, TESTIS AND EPIDIDYMIS GENE EXPRESSION AND EFFECT OF TAMOXIFEN TREATMENT 132
Role of Sexuality in the Outcome of Anorexia Nervosa and Bulimia Nervosa: A 3-Year Follow-Up Study 132
Tadalafil reduces visceral adipose tissue accumulation by promoting preadipocytes differentiation towards a metabolically healthy phenotype: Studies in rabbits. 132
Anti-inflammatory effects of androgens in the human vagina 132
CHILDHOOD SEXUAL ABUSE MODERATES THE RELATIONSHIP BETWEEN SEXUAL FUNCTIONING AND EATING DISORDER PSYCHOPATHOLOGY IN ANOREXIA NERVOSA AND BULIMIA NERVOSA: A 1-YEAR-FOLLOW-UP STUDY. 130
Oxytocin mediates the estrogen-dependent contractile activity of endothelin-1 in human and rabbit epididymis. 130
Anti-inflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells. 130
Benign prostatic hyperplasia: a new metabolic disease? 129
Neural Correlates of Gender Face Perception in Transgender People 129
Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis. 128
Bringing the body of the iceberg to the surface: the Female Sexual Dysfunction Index-6 (FSDI-6) in the screening of female sexual dysfunction 127
FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS. 126
Testosterone therapy: a friend or a foe for the aging men with benign prostatic hyperplasia? 126
Outcome of Medical and Psychosexual Interventions for Vaginismus: A Systematic Review and Meta-Analysis. 126
Testosterone treatment improves metabolic syndrome-induced adipose tissue derangements. 125
PDE5-Is for the Treatment of Concomitant ED and LUTS/BPH 125
Treatment of Functional Hypogonadism Besides Pharmacological Substitution 125
Klinefelter syndrome: cardiovascular abnormalities and metabolic disorders. 124
Testosterone, cardiovascular disease and the metabolic syndrome. 123
Global Consensus Position Statement on the Use of Testosterone Therapy for Women 123
Klinefelter's Syndrome: A Clinical and Therapeutical Update 122
Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens. 121
BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder. 121
Testosterone protects from metabolic syndrome-associated prostate inflammation: An experimental study in rabbit 121
Hypogonadotropic hypogonadism and metabolic syndrome: insights from the high-fat diet experimental rabbit animal model 120
Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway. 119
Cardiovascular risk engines can help in selecting patients to be evaluated by dynamic penile color doppler ultrasound. 119
Therapeutic effects of the selective farnesoid X receptor agonist obeticholic acid in a monocrotaline-induced pulmonary hypertension rat model. 119
Characterization and functional role of androgen-dependent PDE5 activity in the bladder. 118
Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signaling hyperactivation. 118
Validation of a Visual Analogue Scale to measure the subjective perception of orgasmic intensity in females: The Orgasmometer-F 118
LH supplementation of ovarian stimulation protocols influences follicular fluid steroid composition contributing to the improvement of ovarian response in poor responder women. 118
The vitamin D receptor agonist elocalcitol upregulates L-type calcium channel activity in human and rat bladder 117
Therapeutic effects of obeticholic acid (OCA) treatment in a bleomycin-induced pulmonary fibrosis rat model 117
Obesity and hormonal contraception: an overview and a clinician's practical guide 117
Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome. 116
Which Drug to Discontinue 3 Months After Combination Therapy of Tadalafil plus Tamsulosin for Men with Lower Urinary Tract Symptom and Erectile Dysfunction? Results of a Prospective Observational Trial 116
Sexual Health in Menopause 116
Anorectic and Bulimic Patients Suffer from Relevant Sexual Dysfunctions. 116
Metabolic syndrome and prostate abnormalities in male subjects of infertile couples 115
Farnesoid X Receptor Activation Improves Erectile Function in Animal Models of Metabolic Syndrome and Diabetes. 115
Psychobiological Correlates of Vaginismus: An Exploratory Analysis 115
Beneficial effects of bile acid receptor agonists in pulmonary disease models. 115
Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: An experimental study in the rabbit. 114
Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation. 113
Which are the male factors associated with female sexual dysfunction (FSD)? 113
Back to the Future: Is GnRHa treatment in transgender and gender diverse adolescents only an extended evaluation phase? 113
Cardiometabolic Risk and Female Sexuality-Part I. Risk Factors and Potential Pathophysiological Underpinnings for Female Vasculogenic Sexual Dysfunction Syndromes 112
Peripheral regulatory mechanisms in erection 112
Human prostatic urethra expresses Vitamin D receptor and responds to Vitamin D receptor ligation. 112
Low Testosterone Levels Predict Clinical Adverse Outcomes in SARS-CoV-2 Pneumonia Patients 112
Which patients with sexual dysfunction are suitable for testosterone replacement therapy? 111
Oxytocin receptor is expressed in the penis and mediates an estrogen-dependent smooth muscle contractility 111
Risks and benefits of late onset hypogonadism treatment: an expert opinion 111
A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. 109
Sex Steroid Receptors in Male Human Bladder: Expression and Biological Function. 109
Cardiometabolic Risk and Female Sexuality-Part II. Understanding (and Overcoming) Gender Differences: The Key Role of an Adequate Methodological Approach 109
Tadalafil effect on metabolic syndrome-associated bladder alterations: an experimental study in a rabbit model. 108
Totale 14.238
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.896
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.896
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.286 0 0 0 0 0 404 420 433 389 234 315 91
2020/20212.598 197 221 134 418 127 257 139 184 246 354 163 158
2021/20222.029 85 205 301 61 55 77 74 235 96 82 316 442
2022/20234.444 387 995 168 268 290 711 523 224 392 131 122 233
2023/20242.636 72 178 366 132 202 237 181 642 103 245 181 97
2024/20259.682 511 1.320 891 2.008 3.580 1.372 0 0 0 0 0 0
Totale 27.456